Aurobindo Pharma reports 40% rise in Q1 consolidated net profit

08 Aug 2019

Aurobindo Pharma has reported results for first quarter ended June 30, 2019.

The company has reported a rise of 46.81% in its net profit at Rs 330.50 crore for the quarter under review as compared to Rs 225.12 crore for the same quarter in the previous year. Total income of the company increased by 21.37% at Rs 3,108.97 crore for Q1FY20 as compared Rs 2,561.64 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 39.53% in its net profit at Rs 635.68 crore for the quarter under review as compared to Rs 455.59 crore for the same quarter in the previous year. Total income of the company increased by 27.16% at Rs 5,460.38 crore for Q1FY20 as compared Rs 4294.00 crore for the corresponding quarter previous year.

Related Aurobindo Pharma Ltd. Links:

Aurobindo Pharma Share Price

796.55 -5.05 (-0.63%) Sep 29, 16:55
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 505.60
Dr. Reddys Lab 5083.50
Lupin 998.00
Piramal Enterprises 1253.15
Cadila Healthcare 387.55
View more..
Sensex vs Aurobindo Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback